Aplastic anemia: Diagnosis and treatment

Gabrielle Meyers, Curtis Lachowiez

    Research output: Contribution to journalReview article

    Abstract

    Objective: To describe the current approach to diagnosis and treatment of aplastic anemia. Methods: Review of the literature. Results: Aplastic anemia can be acquired or associated with an inherited marrow failure syndrome (IMFS), and the treatment and prognosis vary dramatically between these 2 etiologies. Patients may present along a spectrum, ranging from being asymptomatic with incidental findings on peripheral blood testing to life-threatening neutropenic infections or bleeding. Workup and diagnosis involves investigating IMFSs and ruling out malignant or infectious etiologies for pancytopenia. Conclusion: Treatment outcomes are excellent with modern supportive care and the current approach to allogeneic transplantation, and therefore referral to a bone marrow transplant program to evaluate for early transplantation is the new standard of care for aplastic anemia.

    Original languageEnglish (US)
    Pages (from-to)229-240
    Number of pages12
    JournalJournal of Clinical Outcomes Management
    Volume26
    Issue number5
    StatePublished - Jan 1 2019

    Fingerprint

    Aplastic Anemia
    Bone Marrow
    Pancytopenia
    Incidental Findings
    Homologous Transplantation
    Standard of Care
    Treatment Failure
    Therapeutics
    Referral and Consultation
    Transplantation
    Hemorrhage
    Transplants
    Infection

    Keywords

    • Fanconi anemia
    • Immunosuppression
    • Inherited marrow failure syndrome
    • Stem cell
    • Transplant

    ASJC Scopus subject areas

    • Health Policy

    Cite this

    Aplastic anemia : Diagnosis and treatment. / Meyers, Gabrielle; Lachowiez, Curtis.

    In: Journal of Clinical Outcomes Management, Vol. 26, No. 5, 01.01.2019, p. 229-240.

    Research output: Contribution to journalReview article

    Meyers, Gabrielle ; Lachowiez, Curtis. / Aplastic anemia : Diagnosis and treatment. In: Journal of Clinical Outcomes Management. 2019 ; Vol. 26, No. 5. pp. 229-240.
    @article{fce00c6a4de44f209e570216d01840b8,
    title = "Aplastic anemia: Diagnosis and treatment",
    abstract = "Objective: To describe the current approach to diagnosis and treatment of aplastic anemia. Methods: Review of the literature. Results: Aplastic anemia can be acquired or associated with an inherited marrow failure syndrome (IMFS), and the treatment and prognosis vary dramatically between these 2 etiologies. Patients may present along a spectrum, ranging from being asymptomatic with incidental findings on peripheral blood testing to life-threatening neutropenic infections or bleeding. Workup and diagnosis involves investigating IMFSs and ruling out malignant or infectious etiologies for pancytopenia. Conclusion: Treatment outcomes are excellent with modern supportive care and the current approach to allogeneic transplantation, and therefore referral to a bone marrow transplant program to evaluate for early transplantation is the new standard of care for aplastic anemia.",
    keywords = "Fanconi anemia, Immunosuppression, Inherited marrow failure syndrome, Stem cell, Transplant",
    author = "Gabrielle Meyers and Curtis Lachowiez",
    year = "2019",
    month = "1",
    day = "1",
    language = "English (US)",
    volume = "26",
    pages = "229--240",
    journal = "Journal of Clinical Outcomes Management",
    issn = "1079-6533",
    publisher = "Turner White Communications Inc.",
    number = "5",

    }

    TY - JOUR

    T1 - Aplastic anemia

    T2 - Diagnosis and treatment

    AU - Meyers, Gabrielle

    AU - Lachowiez, Curtis

    PY - 2019/1/1

    Y1 - 2019/1/1

    N2 - Objective: To describe the current approach to diagnosis and treatment of aplastic anemia. Methods: Review of the literature. Results: Aplastic anemia can be acquired or associated with an inherited marrow failure syndrome (IMFS), and the treatment and prognosis vary dramatically between these 2 etiologies. Patients may present along a spectrum, ranging from being asymptomatic with incidental findings on peripheral blood testing to life-threatening neutropenic infections or bleeding. Workup and diagnosis involves investigating IMFSs and ruling out malignant or infectious etiologies for pancytopenia. Conclusion: Treatment outcomes are excellent with modern supportive care and the current approach to allogeneic transplantation, and therefore referral to a bone marrow transplant program to evaluate for early transplantation is the new standard of care for aplastic anemia.

    AB - Objective: To describe the current approach to diagnosis and treatment of aplastic anemia. Methods: Review of the literature. Results: Aplastic anemia can be acquired or associated with an inherited marrow failure syndrome (IMFS), and the treatment and prognosis vary dramatically between these 2 etiologies. Patients may present along a spectrum, ranging from being asymptomatic with incidental findings on peripheral blood testing to life-threatening neutropenic infections or bleeding. Workup and diagnosis involves investigating IMFSs and ruling out malignant or infectious etiologies for pancytopenia. Conclusion: Treatment outcomes are excellent with modern supportive care and the current approach to allogeneic transplantation, and therefore referral to a bone marrow transplant program to evaluate for early transplantation is the new standard of care for aplastic anemia.

    KW - Fanconi anemia

    KW - Immunosuppression

    KW - Inherited marrow failure syndrome

    KW - Stem cell

    KW - Transplant

    UR - http://www.scopus.com/inward/record.url?scp=85073435130&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85073435130&partnerID=8YFLogxK

    M3 - Review article

    AN - SCOPUS:85073435130

    VL - 26

    SP - 229

    EP - 240

    JO - Journal of Clinical Outcomes Management

    JF - Journal of Clinical Outcomes Management

    SN - 1079-6533

    IS - 5

    ER -